28.45 (-%)
As of Nov 20, 2024
Source:
Castle Biosciences is applying innovative diagnostics to inform disease management and improve patient outcomes. For the diseases that our portfolio of tests cover, we believe the traditional approach to developing a treatment plan for cancers and other diseases using clinical and pathology factors alone is inadequate and can be improved by incorporating the personalized information our diagnostic and prognostic (or risk stratification) tests provide.
Country | United States |
Headquarters | friendswood, texas |
Phone Number | 866-788-9007 |
Industry | services |
CEO | Derek J. Maetzold |
Website | www.castlebiosciences.com |